Siegfried Holding AG (0QQO.L)
CHF 978.56
(0.57%)
CHF 978.56
(0.57%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 172.06 Million CHF | -24.4% |
| 2022 | 227.61 Million CHF | 75.05% |
| 2021 | 130.03 Million CHF | 67.99% |
| 2020 | 77.4 Million CHF | 41.08% |
| 2019 | 54.86 Million CHF | -29.32% |
| 2018 | 77.62 Million CHF | 25.56% |
| 2017 | 61.82 Million CHF | 53.99% |
| 2016 | 40.15 Million CHF | -1.89% |
| 2015 | 40.92 Million CHF | 54.15% |
| 2014 | 26.54 Million CHF | -19.13% |
| 2013 | 32.82 Million CHF | 83.16% |
| 2012 | 17.92 Million CHF | 54.32% |
| 2011 | 11.61 Million CHF | 116.6% |
| 2010 | 5.36 Million CHF | 146.5% |
| 2009 | -11.53 Million CHF | 86.38% |
| 2008 | -84.67 Million CHF | -377.85% |
| 2007 | 30.47 Million CHF | -0.5% |
| 2006 | 30.62 Million CHF | -28.64% |
| 2005 | 42.91 Million CHF | 84.91% |
| 2004 | 23.21 Million CHF | -63.12% |
| 2003 | 62.93 Million CHF | -16.54% |
| 2002 | 75.4 Million CHF | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 87.85 Million CHF | 0.0% |
| 2023 Q2 | 75.35 Million CHF | 0.0% |
| 2023 FY | 172.06 Million CHF | -24.4% |
| 2023 Q4 | 91.73 Million CHF | 0.0% |
| 2022 Q2 | 86.54 Million CHF | 0.0% |
| 2022 Q4 | 139.97 Million CHF | 0.0% |
| 2022 FY | 227.61 Million CHF | 75.05% |
| 2021 Q4 | 92.32 Million CHF | 0.0% |
| 2021 Q2 | 35.6 Million CHF | 0.0% |
| 2021 FY | 130.03 Million CHF | 67.99% |
| 2020 Q2 | 28.47 Million CHF | 0.0% |
| 2020 FY | 77.4 Million CHF | 41.08% |
| 2020 Q4 | 48.53 Million CHF | 0.0% |
| 2019 Q4 | 13.82 Million CHF | 0.0% |
| 2019 FY | 54.86 Million CHF | -29.32% |
| 2019 Q2 | 38.74 Million CHF | 0.0% |
| 2018 FY | 77.62 Million CHF | 25.56% |
| 2018 Q2 | 36.68 Million CHF | 0.0% |
| 2018 Q4 | 40.94 Million CHF | 0.0% |
| 2017 Q4 | 31.8 Million CHF | 0.0% |
| 2017 Q2 | 30.02 Million CHF | 0.0% |
| 2017 FY | 61.82 Million CHF | 53.99% |
| 2016 Q4 | 20.27 Million CHF | 0.0% |
| 2016 FY | 40.15 Million CHF | -1.89% |
| 2016 Q2 | 19.87 Million CHF | 0.0% |
| 2015 Q4 | 20.41 Million CHF | 0.0% |
| 2015 Q2 | 20.5 Million CHF | 0.0% |
| 2015 FY | 40.92 Million CHF | 54.15% |
| 2014 Q2 | 16.65 Million CHF | 0.0% |
| 2014 FY | 26.54 Million CHF | -19.13% |
| 2014 Q4 | 9.89 Million CHF | 0.0% |
| 2013 FY | 32.82 Million CHF | 83.16% |
| 2013 Q4 | 17.88 Million CHF | 0.0% |
| 2013 Q2 | 14.94 Million CHF | 0.0% |
| 2012 FY | 17.92 Million CHF | 54.32% |
| 2012 Q4 | 13.33 Million CHF | 206.09% |
| 2012 Q3 | 4.35 Million CHF | 0.0% |
| 2012 Q2 | 4.35 Million CHF | 0.0% |
| 2012 Q1 | 4.35 Million CHF | 0.0% |
| 2011 Q3 | 2.87 Million CHF | 0.0% |
| 2011 Q2 | 2.87 Million CHF | 0.0% |
| 2011 Q1 | 2.87 Million CHF | 0.0% |
| 2011 FY | 11.61 Million CHF | 116.6% |
| 2011 Q4 | 4.35 Million CHF | 51.4% |
| 2010 FY | 5.36 Million CHF | 146.5% |
| 2010 Q4 | 2.87 Million CHF | 267.47% |
| 2010 Q3 | -1.71 Million CHF | 0.0% |
| 2010 Q2 | -1.71 Million CHF | 0.0% |
| 2010 Q1 | -1.71 Million CHF | 0.0% |
| 2009 Q2 | -6.7 Million CHF | 0.0% |
| 2009 Q4 | -1.71 Million CHF | 74.36% |
| 2009 FY | -11.53 Million CHF | 86.38% |
| 2009 Q3 | -6.7 Million CHF | 0.0% |
| 2009 Q1 | -6.7 Million CHF | 0.0% |
| 2008 Q2 | -20.51 Million CHF | 0.0% |
| 2008 Q4 | -6.7 Million CHF | 67.34% |
| 2008 FY | -84.67 Million CHF | -377.85% |
| 2008 Q3 | -20.51 Million CHF | 0.0% |
| 2008 Q1 | -20.51 Million CHF | 0.0% |
| 2007 Q3 | 14.6 Million CHF | 0.0% |
| 2007 FY | 30.47 Million CHF | -0.5% |
| 2007 Q4 | -20.51 Million CHF | -240.51% |
| 2007 Q2 | 14.6 Million CHF | 0.0% |
| 2007 Q1 | 14.6 Million CHF | 0.0% |
| 2006 Q2 | 10.69 Million CHF | 0.0% |
| 2006 Q1 | 10.69 Million CHF | 0.0% |
| 2006 FY | 30.62 Million CHF | -28.64% |
| 2006 Q4 | 14.6 Million CHF | 36.5% |
| 2006 Q3 | 10.69 Million CHF | 0.0% |
| 2005 FY | 42.91 Million CHF | 84.91% |
| 2005 Q4 | 10.69 Million CHF | 0.29% |
| 2005 Q2 | 10.66 Million CHF | 0.0% |
| 2005 Q1 | 10.66 Million CHF | 0.0% |
| 2005 Q3 | 10.66 Million CHF | 0.0% |
| 2004 FY | 23.21 Million CHF | -63.12% |
| 2004 Q1 | 4.69 Million CHF | 0.0% |
| 2004 Q2 | 4.69 Million CHF | 0.0% |
| 2004 Q3 | 4.69 Million CHF | 0.0% |
| 2004 Q4 | 10.66 Million CHF | 127.25% |
| 2003 Q3 | 14.8 Million CHF | 0.0% |
| 2003 Q2 | 14.8 Million CHF | 0.0% |
| 2003 FY | 62.93 Million CHF | -16.54% |
| 2003 Q4 | 4.69 Million CHF | -68.3% |
| 2003 Q1 | 14.8 Million CHF | 0.0% |
| 2002 Q1 | 17.29 Million CHF | 0.0% |
| 2002 Q2 | 17.29 Million CHF | 0.0% |
| 2002 FY | 75.4 Million CHF | 0.0% |
| 2002 Q3 | 17.29 Million CHF | 0.0% |
| 2002 Q4 | 14.8 Million CHF | -14.4% |
| 2001 Q4 | 17.29 Million CHF | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Relief Therapeutics Holding AG | -110.82 Million CHF | 255.257% |
| Tecan Group AG | 135.96 Million CHF | -26.551% |
| Santhera Pharmaceuticals Holding AG | 68.84 Million CHF | -149.939% |
| Basilea Pharmaceutica AG | 19.2 Million CHF | -795.954% |
| Bachem Holding AG | 129.38 Million CHF | -32.994% |
| Molecular Partners AG | -61.1 Million CHF | 381.58% |